Scinovex
articleTop 1% cited

Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

British Journal of Haematology · 2008 · Vol. 141(5) · pp. 672–675
Charles H. LawrieShira GalHeather M. DunlopBeena PushkaranAmanda P. LigginsKaren PulfordAlison H. BanhamFrancesco PezzellaJacqueline BoultwoodJames S. WainscoatChristian S. R. HattonAdrian L. Harris

Abstract

Circulating nucleic acids have been shown to have potential as non-invasive diagnostic markers in cancer. We therefore investigated whether microRNAs also have diagnostic utility by comparing levels of tumour-associated MIRN155 (miR-155), MIRN210 (miR-210) and MIRN21 (miR-21) in serum from diffuse large B-cell lymphoma (DLBCL) patients (n = 60) with healthy controls (n = 43). Levels were higher in patient than control sera (P = 0.009, 0.02 and 0.04 respectively). Moreover, high MIRN21 expression was associated with relapse-free survival (P = 0.05). This is the first description of circulating microRNAs and suggests that microRNAs have potential as non-invasive diagnostic markers for DLBCL and possibly other cancers.

MicroRNA in disease regulationRNA Research and SplicingRNA modifications and cancermicroRNADiffuse large B-cell lymphomaLymphomaMedicineCancerInternal medicineOncologyHematologyCase-control studyPathology

MeSH terms

AdultFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesRNA, NeoplasmBiomarkers, TumorSurvival AnalysisLymphoma, Large B-Cell, DiffuseMicroRNAs
Citations
1,738
FWCI
28.50
field-weighted impact
References
12
Percentile
100%
vs. same field & year
Citations per year
References
miR-21-mediated tumor growth
Oncogene · 2006 · 1,594 citations
A MicroRNA Signature of Hypoxia
Molecular and Cellular Biology · 2006 · 1,059 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.